J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
Want to cut your energy bills? Here’s how five experts are doing it 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
NEW YORK, March 08, 2016 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Chris Pasquale will join the equity research department as a Director covering the Medical Supplies and Devices sector. He will commence work at Guggenheim in April.
Mr. Pasquale will be coming to Guggenheim from J.P. Morgan, where he worked on the top-ranked medical supplies and devices team, according to the Institutional Investor Magazine 2015 Rankings.
“We are excited to have Chris on our Healthcare team,” said John Hervey, Director of Research at Guggenheim Securities. “His company coverage brings an important new dimension to our Healthcare coverage; strengthens the outstanding fundamental research team of Tony Butler, Louise Chen, and Bill Tanner; as well as complements the outstanding policy research that we produce through our Washington Research Group.”
Mr. Pasquale earned his B.S. at Duke University. He will operate out of Philadelphia, where he resides.
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers a full range of services that fall into four broad categories: Advisory, Sales and Trading, Financing, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Atlanta, Boston, Chicago, Los Angeles, and San Francisco. For more information, visit guggenheimpartners.com.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $240 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1Assets under management are as of 12.31.2015 and include consulting services for clients whose assets are valued at approximately $47bn.
Media Contact Ellen Cunningham Guggenheim Partners 212.518.9578 [email protected]
